University Hospital of Frankfurt (GUF)
University Hospital of Frankfurt, Frankfurt/Main, Germany
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy Deutschordenstraße 50
D-60528 Frankfurt am Main
GU Frankfurt is one of the leading Universities in Germany; the Medical Faculty is continuously positioned among the 51-75 best Universities worldwide in the Shanghai Ranking. The department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (CAPPP) serves the Frankfurt area (>1 Mio inhabitants). It has 4 inpatient & 3 day clinic wards, and a large outpatient clinic (> 2000 patients/year). At CAPPP a special outpatient clinic for Attention-Deficit / Hyperactivity Disorder (ADHD) integrate clinical care with advanced research. Individuals with ADHD are diagnosed and treated according to the current standard of evidence based medicine, and studies on genetics, molecular biology, brain imaging, neurophysiology, neuropsychology, diagnostic procedures as well as clinical trials are performed. CAPP serves around 300 ADHD individuals per year. Research at CAPPP is organized in 4 areas: (1) clinical research (multi-centre RCT on ASD funded by the German Research Foundation [DFG] FR2069/2-1 PI CMF, multi-centre RCT on ADHD funded by the EC, H2020 CoCa No. 667302, PI CMF; diagnostic review on ASD funded by the German Ministry of Education BMBF 01KG1220, PI CMF; EC FP7 research project No. 602407 FemNAT-CD, Coordinator CMF); (2) neuropsychology lab (attention, executive function & emotion processing studies; current funding by the EC, ETN MiND No. 643051 to CMF); (3) neurophysiology and brain-imaging labs (current funding by the DFG (Heisenberg Professorship EC480/1-1 and research project DFG EC480/2-1); (3) molecular biological lab (genetic & proteomic studies; current funding by the EC (No. 602407 FemNAT-CD; coordinator CMF).
Prof. Dr. Christine M. Freitag is head of the department since 12/2008, and has a long track record on clinical, brain imaging, and genetic studies in ASD. She is member of the Psychiatric Genetics (PGC) and IMAGE II consortium. She has published > 200 peer reviewed articles (cumulative impact CI > 1000; current H-Index 33).